These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 26771848)
1. Genomic landscape of intracranial meningiomas. Bi WL; Abedalthagafi M; Horowitz P; Agarwalla PK; Mei Y; Aizer AA; Brewster R; Dunn GP; Al-Mefty O; Alexander BM; Santagata S; Beroukhim R; Dunn IF J Neurosurg; 2016 Sep; 125(3):525-35. PubMed ID: 26771848 [TBL] [Abstract][Full Text] [Related]
2. Genomic and Epigenomic Landscape in Meningioma. Bi WL; Mei Y; Agarwalla PK; Beroukhim R; Dunn IF Neurosurg Clin N Am; 2016 Apr; 27(2):167-79. PubMed ID: 27012381 [TBL] [Abstract][Full Text] [Related]
3. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation. Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203 [TBL] [Abstract][Full Text] [Related]
5. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Clark VE; Erson-Omay EZ; Serin A; Yin J; Cotney J; Ozduman K; Avşar T; Li J; Murray PB; Henegariu O; Yilmaz S; Günel JM; Carrión-Grant G; Yilmaz B; Grady C; Tanrikulu B; Bakircioğlu M; Kaymakçalan H; Caglayan AO; Sencar L; Ceyhun E; Atik AF; Bayri Y; Bai H; Kolb LE; Hebert RM; Omay SB; Mishra-Gorur K; Choi M; Overton JD; Holland EC; Mane S; State MW; Bilgüvar K; Baehring JM; Gutin PH; Piepmeier JM; Vortmeyer A; Brennan CW; Pamir MN; Kiliç T; Lifton RP; Noonan JP; Yasuno K; Günel M Science; 2013 Mar; 339(6123):1077-80. PubMed ID: 23348505 [TBL] [Abstract][Full Text] [Related]
6. Brain-invasive meningiomas: molecular mechanisms and potential therapeutic options. Qin C; Huang M; Pan Y; Li Y; Long W; Liu Q Brain Tumor Pathol; 2021 Jul; 38(3):156-172. PubMed ID: 33903981 [TBL] [Abstract][Full Text] [Related]
7. [18FDG-PET in intracranial meningiomas versus grading, proliferation index, cellular density and cytogenetic analysis]. Cremerius U; Striepecke E; Henn W; Weis J; Mull M; Lippitz B; Gilsbach J; Schröder JM; Zang KD; Böcking A Nuklearmedizin; 1994 Aug; 33(4):144-9. PubMed ID: 7971289 [TBL] [Abstract][Full Text] [Related]
8. Histological classification and molecular genetics of meningiomas. Riemenschneider MJ; Perry A; Reifenberger G Lancet Neurol; 2006 Dec; 5(12):1045-54. PubMed ID: 17110285 [TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor receptor-3 expression in meningiomas with stimulation of proliferation by the phosphoinositide 3 kinase-Akt pathway. Johnson MD; O'Connell MJ; Pilcher W; Reeder JE J Neurosurg; 2010 May; 112(5):934-9. PubMed ID: 19698046 [TBL] [Abstract][Full Text] [Related]
10. Molecular alterations in meningioma: prognostic and therapeutic perspectives. Birzu C; Peyre M; Sahm F Curr Opin Oncol; 2020 Nov; 32(6):613-622. PubMed ID: 32890025 [TBL] [Abstract][Full Text] [Related]
11. Loss of chromosome 22 and absence of NF2 gene mutation in a case of multiple meningiomas. Lomas J; Bello MJ; Alonso ME; Gonzalez-Gomez P; Arjona D; Kusak ME; de Campos JM; Sarasa JL; Rey JA Hum Pathol; 2002 Mar; 33(3):375-8. PubMed ID: 11979381 [TBL] [Abstract][Full Text] [Related]
12. High-grade meningiomas: biology and implications. Bi WL; Prabhu VC; Dunn IF Neurosurg Focus; 2018 Apr; 44(4):E2. PubMed ID: 29606053 [TBL] [Abstract][Full Text] [Related]
13. Cytogenetic changes in 67 cranial and spinal meningiomas: relation to histopathological and clinical pattern. Doco-Fenzy M; Cornillet P; Scherpereel B; Depernet B; Bisiau-Leconte S; Ferre D; Pluot M; Graftiaux JP; Teyssier JR Anticancer Res; 1993; 13(4):845-50. PubMed ID: 8352553 [TBL] [Abstract][Full Text] [Related]
14. Molecular genetics of meningiomas: from basic research to potential clinical applications. Simon M; Boström JP; Hartmann C Neurosurgery; 2007 May; 60(5):787-98; discussion 787-98. PubMed ID: 17460514 [TBL] [Abstract][Full Text] [Related]
15. [The Potential of Personalized/Precision Medicine for Meningiomas]. Yamaguchi S; Fujimura M No Shinkei Geka; 2022 Jan; 50(1):132-140. PubMed ID: 35169093 [TBL] [Abstract][Full Text] [Related]
16. Clinical potential of meningioma genomic insights: a practical review for neurosurgeons. Karsy M; Azab MA; Abou-Al-Shaar H; Guan J; Eli I; Jensen RL; Ormond DR Neurosurg Focus; 2018 Jun; 44(6):E10. PubMed ID: 29852774 [TBL] [Abstract][Full Text] [Related]
18. Related mechanisms, current treatments, and new perspectives in meningioma. Inetas-Yengin G; Bayrak OF Genes Chromosomes Cancer; 2024 May; 63(5):e23248. PubMed ID: 38801095 [TBL] [Abstract][Full Text] [Related]
19. Current treatment options for meningioma. Apra C; Peyre M; Kalamarides M Expert Rev Neurother; 2018 Mar; 18(3):241-249. PubMed ID: 29338455 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus. Hansson CM; Buckley PG; Grigelioniene G; Piotrowski A; Hellström AR; Mantripragada K; Jarbo C; Mathiesen T; Dumanski JP BMC Genomics; 2007 Jan; 8():16. PubMed ID: 17222329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]